FDA Clearance Tracker · P020014-S046
ESSURE SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 15, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Nov 15, 2016
Approved
Time to decision
180 days
Received May 19, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020014-S046
- Device name
- ESSURE SYSTEM
- Applicant
- Bayer Pharma AG
- Applicant location
- Berlin
- Received
- May 19, 2016
- Decided
- Nov 15, 2016
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P020014
Device type
- Device class
- Class III
- Regulation
- 21 CFR 884.5380
- Specialty
- Obstetrics & Gynecology
FDA's approval statement
As written in FDA's record.
Approval for changes to the physicians instructions for use and patient information booklet including a boxed warning and a patient decision checklist.
Source documents
Other decisions for Bayer Pharma AG
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.